que es mejor tirzepatide o semaglutide vs. Tirzepatide: Which Drug Leads to More Weight Loss and for Whom Tirzepatida vs Semaglutida. Diferencias y

Daha uzun sreli antrenman olana salayabilir

All experimental design parametersincluding concentration, protocol, and handlingmust be determined by the purchasing laboratory

Key Findings 1 Tirzepatide reduced major kidney events by 23% vs dulaglutide Events: 6.0% vs 7.6% HR 0.77 (95% CI 0.680.88), p=0.0002 The risk of the primary composite kidney outcomewas 23% lower with tirzepatide than with dulaglutide. 2 Benefits were consistent across CKD risk categories Lowtomoderate risk CKD: HR 0.70 Highrisk CKD: HR 0.79 3 Mechanistic drivers differed by CKD stage Lowtomoderate CKD: Less newonset macroalbuminuria Highrisk CKD: Slower eGFR decline This was primarily driven by a lower rate of new-onset persistent macroalbuminuria and a lower rate of eGFR decline. 4 eGFR decline was significantly slower with tirzepatide Overall difference: +0.29 mL/min/1.73 m per year Highrisk CKD: +0.93 mL/min/1.73 m per year 5 Albuminuria improved more with tirzepatide At 36 months, UACR reductions were greater across CKD categories

See our guide on semaglutide alternatives for context

Intriguingly, TZP therapy has been postulated to exhibit reduced aversive and gastrointestinal side effects in part due to central antiaversive actions of GIP (42)

Beyond 4 weeks: Tirzepatide is considered completely cleared from your system